Cargando…

Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis

In making policy decisions with constrained resources, an important consideration is the impact of alternative policy options on social justice. Social justice considers interactions between individuals and society and can be conceptualized across domains of agency, association, and respect. Despite...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dowdy, David W., Zwerling, Alice A., Stennett, Andrea, Searle, Alexandra, Dukhanin, Vadim, Taylor, Holly A., Merritt, Maria W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227142/ https://www.ncbi.nlm.nih.gov/pubmed/32440569 http://dx.doi.org/10.1177/2381468320915239

Ejemplares similares

Mathematical Modelling and Tuberculosis: Advances in Diagnostics and Novel Therapies
por: Zwerling, Alice, et al.
Publicado: (2015)

Bridging the gap between evidence and policy for infectious diseases: How models can aid public health decision-making
por: Knight, Gwenan M., et al.
Publicado: (2015)

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis
por: Kendall, Emily A, et al.
Publicado: (2017)

The Impact and Cost-Effectiveness of a Four-Month Regimen for First-Line Treatment of Active Tuberculosis in South Africa
por: Knight, Gwenan M., et al.
Publicado: (2015)

Understanding spending trends for tuberculosis
por: Zwerling, Alice
Publicado: (2020)

Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations
por: Zwerling, Alice, et al.
Publicado: (2014)

Immigration Policy and Justice in the Era of COVID-19
por: Miller, Holly Ventura, et al.
Publicado: (2020)

Metrics and Evaluation Tools for Patient Engagement in Healthcare Organization- and System-Level Decision-Making: A Systematic Review
por: Dukhanin, Vadim, et al.
Publicado: (2018)

Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model
por: Moses, Mark W., et al.
Publicado: (2016)

Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis
por: Jain, Kalpesh, et al.
Publicado: (2014)

Aggressive Regimens for Multidrug-Resistant Tuberculosis Decrease All-Cause Mortality
por: Mitnick, Carole D., et al.
Publicado: (2013)

Drivers and Trajectories of Resistance to New First-Line Drug Regimens for Tuberculosis
por: Shrestha, Sourya, et al.
Publicado: (2014)

Time to Culture Conversion and Regimen Composition in Multidrug-Resistant Tuberculosis Treatment
por: Tierney, Dylan B., et al.
Publicado: (2014)

Short-Course Regimen for Multidrug-Resistant Tuberculosis: A Decade of Evidence
por: Trébucq, Arnaud, et al.
Publicado: (2019)

Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives
por: Pontali, Emanuele, et al.
Publicado: (2019)

Analysing disability policy in Namibia: An occupational justice perspective
por: Chichaya, Tongai F., et al.
Publicado: (2018)

Forecasting and Criminal Justice Policy and Practice
por: Sabol, William J., et al.
Publicado: (2022)

MDR-TB treatment as prevention: The projected population-level impact of expanded treatment for multidrug-resistant tuberculosis
por: Kendall, Emily A., et al.
Publicado: (2017)

Population-Level Impact of Shorter-Course Regimens for Tuberculosis: A Model-Based Analysis
por: Fofana, Mariam O., et al.
Publicado: (2014)

Brexit and trade policy: an analysis of the governance of UK trade policy and what it means for health and social justice
por: van Schalkwyk, May C. I., et al.
Publicado: (2021)

Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
por: Achar, Jay, et al.
Publicado: (2015)

Shorter & cheaper regimen to treat multidrug-resistant tuberculosis: A new hope
por: Prasad, Rajendra, et al.
Publicado: (2017)

What’s Next for the Standard Short-Course Regimen for Treatment of Multidrug-Resistant Tuberculosis
por: Campbell, Jonathon R., et al.
Publicado: (2019)

Outcomes with a shorter multidrug-resistant tuberculosis regimen from Karakalpakstan, Uzbekistan
por: du Cros, Philipp, et al.
Publicado: (2021)

The Why, Who, What, How, and When of Patient Engagement in Healthcare Organizations: A Response to Recent Commentaries
por: Dukhanin, Vadim, et al.
Publicado: (2019)

Sentencing Policy, Social Values and Discretionary Justice
por: Henham, Ralph
Publicado: (2022)

Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens
por: Park, Hae-Young, et al.
Publicado: (2023)

US cities increasingly integrate justice into climate planning and create policy tools for climate justice
por: Diezmartínez, Claudia V., et al.
Publicado: (2022)

Possible impact of the standardized Category IV regimen on multidrug-resistant tuberculosis patients in Mumbai
por: Udwadia, Zarir F, et al.
Publicado: (2016)

Cost-Effectiveness of Adding Bedaquiline to Drug Regimens for the Treatment of Multidrug-Resistant Tuberculosis in the UK
por: Wolfson, Lara J., et al.
Publicado: (2015)

Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China
por: Xia, Hui, et al.
Publicado: (2020)

Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety
por: Gao, Jing-Tao, et al.
Publicado: (2021)

Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Hatami, Hossein, et al.
Publicado: (2022)

Delamanid-containing regimens and multidrug-resistant tuberculosis: A systematic review and meta-analysis
por: Nasiri, Mohammad Javad, et al.
Publicado: (2022)

At Long Last: Short, All-Oral Regimens for Multidrug-Resistant Tuberculosis in the United States
por: Sinha, Pranay, et al.
Publicado: (2023)

Transforming Policy into Justice: The Role of Health Advocates in Mozambique
por: Feinglass, Ellie, et al.
Publicado: (2016)

Ecological limits: Science, justice, policy, and the good life
por: Green, Fergus
Publicado: (2021)

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model
por: Kendall, Emily A., et al.
Publicado: (2017)

Quantitative Drug-Susceptibility in Patients Treated for Multidrug-Resistant Tuberculosis in Bangladesh: Implications for Regimen Choice
por: Heysell, Scott K., et al.
Publicado: (2015)

Rapid diagnosis and shorter regimen for multidrug-resistant tuberculosis: A priority to improve treatment outcome
por: Prasad, Rajendra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4uiu6i1o1hrtcf3gq8d0avmj46